KYMR
Kymera Therapeutics, Inc. Common Stock
$69.93
0.00%
0.00
Notify me if price changes either direction
Buy KYMR stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
5.6B
Enterprise value
4.6B
Trailing PE
-23.466443055428
Forward PE
-18.975594
PEG Ratio
-1.6035402754543
Enterprise to EBITDA
-14.337
Enterprise to revenue
105.401
Price to book MRQ
5.301744
Price to sales TTM
127.91429
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
43.7M
EBITDA
-321535008
Diluted EPS TTM
-3.6
Total Cash (MRQ)
505.7M
Current ratio (MRQ)
7.381
Operating Cash Flow (TTM)
-227928000
KYMR trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
